Pfizer CEO Prefers Annual Vaccination to Booster Shots

Albert Bourla, the CEO of Pfizer Inc., said that the process of annual vaccination against COVID-19 would be more effective than booster shots, Reuters reported on Sunday.

Bourla described that injecting people with booster shots every four or five months would not be  a preferable scenario, saying: “Once a year – it is easier to convince people to do it. It is easier for people to remember.”

He added: “So from a public health perspective, it is an ideal situation. We are looking to see if we can create a vaccine that covers Omicron and doesn’t forget the other variants, and that could be a solution."

Regarding Pfizer’s upcoming vaccine that tracks Omicron variant, the leading corporation’s CEO said that it would be ready for being approved by the US Food and Drug Administration (FDA) by March.

In the same context, the US Centers for Disease Control and Prevention (CDC) revealed that the third shot of an mRNA technology-based vaccine could provide 90% protection against the risks of hospitalization by Omicron variant.

Last month, early analysis of Omicron and Delta cases in the UK revealed that three doses of Pfizer vaccine could be the key against Omicron.

The new analysis revealed that two Pfizer vaccine doses are not enough to protect against the Omicron variant, so adding the third vaccine dose provided more than 75% protection.

In addition, it succeeded in preventing the symptoms of COVID-19 by 75%.

The Secretary of State Michael Gove warned the UK of the "deeply concerning situation," adding, "Action is absolutely required, and as new data comes in, we will consider what action we do require to take in the face of that data."